Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate GlobeNewswire February 02, 2026 Product is currently under review with the FDA Potential approval and launch mid-2026 DEER PARK, Ill., Feb. 02, 2026 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for […]